Serum brain-derived neurotrophic factor and antidepressant-naive major depression after lung cancer diagnosis

Japanese Journal of Clinical Oncology

Volumn 41, Issue 10, 2011, Pages 1233-1237

  Kobayakawa, Makoto ^a,b   Inagaki, Masatoshi ^c   Fujimori, Maiko ^a   Hamazaki, Kei ^d   Hamazaki, Tomohito ^d   Akechi, Tatsuo ^a,e   Tsugane, Shoichiro ^f   Nishiwaki, Yutaka ^a   Goto, Koichi ^a   Hashimoto, Kenji ^g   Yamawaki, Shigeto ^b   Uchitomi, Yosuke ^a,h  

^a NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

^c National Institute of Neurology and Psychiatry   (Japan)

^d UNIVERSITY OF TOYAMA   (Japan)

^e NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^f NATIONAL CANCER CENTER   (Japan)

^g CHIBA UNIVERSITY   (Japan)

^h OKAYAMA UNIVERSITY   (Japan)

Author keywords

BDNF; Cancer diagnosis; Lung cancer; Major depression; Stressful event

Indexed keywords

ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR;

AGED; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FUNCTIONAL STATUS; GENDER; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PROTEIN BLOOD LEVEL; SEX DIFFERENCE;

AGED; BIOLOGICAL MARKERS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CASE-CONTROL STUDIES; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; JAPAN; LIFE CHANGE EVENTS; LUNG NEOPLASMS; MALE; MATCHED-PAIR ANALYSIS; SEX FACTORS;

EID: 80053501842     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyr119     Document Type: Article

References (19)

1. Derogatis LR, Morrow GR, Fetting J, Penman D, Piasetsky S, Schmale AM, et al. The prevalence of psychiatric disorders among cancer patients. JAMA 1983;249:751-7.
2. Kendler KS, Karkowski LM, Prescott CA. Causal relationship between stressful life events and the onset of major depression. Am J Psychiatry 1999;156:837-41.
3. Chochinov HM. Depression in cancer patients. Lancet Oncol 2001;2:499-505.
4. Duman RS, Heninger GR, Nestler EJ. A molecular and cellular theory of depression. Arch Gen Psychiatry 1997;54:597-606.
5. Vaidya VA, Marek GJ, Aghajanian GK, Duman RS. 5-HT2A receptor-mediated regulation of brain-derived neurotrophic factor mRNA in the hippocampus and the neocortex. J Neurosci 1997;17:2785-95.
6. Smith MA, Makino S, Kvetnansky R, Post RM. Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci 1995;15:1768-77.
7. Nibuya M, Morinobu S, Duman RS. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 1995;15:7539-47.
8. Shimizu E, Hashimoto K, Okamura N, Koike K, Komatsu N, Kumakiri C, et al. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry 2003;54:70-5.
9. Karege F, Bondolfi G, Gervasoni N, Schwald M, Aubry JM, Bertschy G. Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity. Biol Psychiatry 2005;57:1068-72.
10. Huang T-L, Lee C-T, Liu Y-L. Serum brain-derived neurotrophic factor levels in patients with major depression: effects of antidepressants. J Psychiatr Res 2008;42:521-5.
11. Kobayakawa M, Yamawaki S, Hamazaki K, Akechi T, Inagaki M, Uchitomi Y. Levels of omega-3 fatty acid in serum phospholipids and depression in patients with lung cancer. Br J Cancer 2005;93:1329-33.
12. Nakaya N, Goto K, Saito-Nakaya K, Inagaki M, Otani T, Akechi T, et al. The Lung Cancer Database Project at the National Cancer Center, Japan: study design, corresponding rate, and profiles of cohort. Jpn J Clin Ooncol 2006;36:280-4.
13. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta PsychiatrScand 1983;67:361-70.
14. Kugaya A, Akechi T, Okuyama T, Okamura H, Uchitomi Y. Screening for psychological distress in Japanese cancer patients. Jpn J Clin Oncol 1998;28:333-8.
15. Inagaki M, Matsuoka Y, Sugahara Y, Nakano T, Akechi T, Fujimori M, et al. Hippocampal volume and first major depressive episode after cancer diagnosis in breast cancer survivors. Am J Psychiatry 2004;161:2263-70.
16. Molendijk ML, Bus BA, Spinhoven P, Penninx BW, Kenis G, Prickaerts J, et al. Serum levels of brain-derived neurotrophic factor in major depressive disorder: state-trait issues, clinical features and pharmacological treatment. Mol Psychiatry advance online publication 21 September 2010; doi:10.1038/mp.2010.98 (in press).
17. Lommatzsch M, Zingler D, Schuhbaeck K, Schloetcke K, Zingler C, Schuff-werner P, et al. The impact of age, weight and gender on BDNF levels in human platelets and plasma. Neurobiol Aging 2005;26: 115-23.
18. Cavus I, Duman RS. Influence of estradiol, stress, and 5-HT2A agonist treatment on brain-derived neurotrophic factor expression in female rats. Biol Psychiatry 2003;54:59-69.
19. Pan W, Banks WA, Fasold MB, Bluth J, Kastin AJ. Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology 1998;37:1553-61.